{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:14:43Z","timestamp":1793942083589,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774069, 81570614"],"award-info":[{"award-number":["81774069, 81570614"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There have been few systematic studies regarding clearance of uric acid (UA) in patients undergoing peritoneal dialysis (PD). This study investigated peritoneal UA removal and its influencing factors in patients undergoing PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study enrolled patients who underwent peritoneal equilibration test and assessment of Kt\/V from April 1, 2018 to August 31, 2019. Demographic data and clinical and laboratory parameters were collected, including UA levels in dialysate, blood, and urine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 180 prevalent patients undergoing PD (52.8% men) were included. Compared with the normal serum UA (SUA) group, the hyperuricemia group showed significantly lower peritoneal UA clearance (39.1\u2009\u00b1\u20096.2 vs. 42.0\u2009\u00b1\u20098.0\u2009L\/week\/1.73m\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.008). Furthermore, higher transporters (high or high-average) exhibited greater peritoneal UA clearance, compared with lower transporters (low or low-average) (42.0\u2009\u00b1\u20097.0 vs. 36.4\u2009\u00b1\u20095.6\u2009L\/week\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Among widely used solute removal indicators, peritoneal creatinine clearance showed the best performance for prediction of higher peritoneal UA clearance in receiver operating characteristic curve analysis [area under curve (AUC) 0.96; 95% confidence interval [CI], 0.93\u20130.99]. Peritoneal UA clearance was independently associated with continuous SUA [standardized coefficient (\u03b2), \u2212\u20090.32; 95% CI, \u2212\u20096.42 to \u2212\u20090.75] and hyperuricemia [odds ratio (OR), 0.86; 95% CI, 0.76\u20130.98] status, only in patients with lower (\u22642.74\u2009mL\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      ) measured glomerular filtration rate (mGFR). In those patients with lower mGFR, lower albumin level (\u03b2 \u2212\u20090.24; 95%CI \u2212\u20097.26 to \u2212\u20090.99), lower body mass index (\u03b2 \u2212\u20090.29; 95%CI \u2212\u20090.98 to \u2212\u20090.24), higher transporter status (\u03b2 0.24; 95%CI 0.72\u20135.88) and greater dialysis dose (\u03b2 0.24; 95%CI 0.26\u20133.12) were independently associated with continuous peritoneal UA clearance. Furthermore, each 1\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      decrease in body mass index (OR 0.79; 95% CI 0.63\u20130.99), each 1\u2009g\/dL decrease in albumin level (OR 0.08; 95%CI 0.01\u20130.47), and each 0.1% increase in average glucose concentration in dialysate (OR 1.56; 95%CI 1.11\u20132.19) were associated with greater peritoneal UA clearance (&gt;\u200939.8\u2009L\/week\/1.73m\n                      <jats:sup>2<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For patients undergoing PD who exhibited worse residual kidney function, peritoneal clearance dominated in SUA balance. Increasing dialysis dose or average glucose concentration may aid in controlling hyperuricemia in lower transporters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01800-1","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T14:03:33Z","timestamp":1587823413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Roles of peritoneal clearance and residual kidney removal in control of uric acid in patients on peritoneal dialysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Xi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"1800_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","volume":"484","author":"G Ndrepepa","year":"2018","unstructured":"Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150\u201363.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1800_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/sdi.12735","volume":"32","author":"M Murea","year":"2019","unstructured":"Murea M, Tucker BM. The physiology of uric acid and the impact of end-stage kidney disease and dialysis. Semin Dial. 2019;32(1):47\u201357.","journal-title":"Semin Dial"},{"issue":"10055","key":"1800_CR3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039\u201352.","journal-title":"Lancet"},{"issue":"9711","key":"1800_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318\u201328.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1800_CR5","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar1909","volume":"8","author":"R Terkeltaub","year":"2006","unstructured":"Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther. 2006;8(Suppl 1):S4.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"1800_CR6","doi-asserted-by":"publisher","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","volume":"7","author":"E Krishnan","year":"2012","unstructured":"Krishnan E. Reduced glomerular function and prevalence of gout: NHANES 2009\u201310. PLoS One. 2012;7(11):e50046.","journal-title":"PLoS One"},{"issue":"2","key":"1800_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90\u2013103.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"1800_CR8","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3109\/0886022X.2014.947516","volume":"36","author":"P Dousdampanis","year":"2014","unstructured":"Dousdampanis P, Trigka K, Musso CG, Fourtounas C. Hyperuricemia and chronic kidney disease: an enigma yet to be solved. Ren Fail. 2014;36(9):1351\u20139.","journal-title":"Ren Fail"},{"issue":"6","key":"1800_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.ackd.2012.07.008","volume":"19","author":"M Murea","year":"2012","unstructured":"Murea M. Advanced kidney failure and hyperuricemia. Adv Chronic Kidney Dis. 2012;19(6):419\u201324.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"1800_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","volume":"50","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50(2):239\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1800_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00467-011-1875-0","volume":"26","author":"DM Silverstein","year":"2011","unstructured":"Silverstein DM, Srivaths PR, Mattison P, Upadhyay K, Midgley L, Moudgil A, et al. Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients. Pediatr Nephrol. 2011;26(7):1123\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"1800_CR12","first-page":"1750","volume":"32","author":"C Park","year":"2017","unstructured":"Park C, Obi Y, Streja E, Rhee CM, Catabay CJ, Vaziri ND, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"24","key":"1800_CR13","doi-asserted-by":"publisher","first-page":"e3701","DOI":"10.1097\/MD.0000000000003701","volume":"95","author":"E Bae","year":"2016","unstructured":"Bae E, Cho HJ, Shin N, Kim SM, Yang SH, Kim DK, et al. Lower serum uric acid level predicts mortality in dialysis patients. Medicine. 2016;95(24):e3701.","journal-title":"Medicine"},{"issue":"10","key":"1800_CR14","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.2215\/CJN.00670111","volume":"6","author":"W Latif","year":"2011","unstructured":"Latif W, Karaboyas A, Tong L, Winchester JF, Arrington CJ, Pisoni RL, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2\u20133","key":"1800_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000350143","volume":"37","author":"S Feng","year":"2013","unstructured":"Feng S, Jiang L, Shi Y, Shen H, Shi X, Jin D, et al. Uric acid levels and all-cause mortality in peritoneal dialysis patients. Kidney Blood Press Res. 2013;37(2\u20133):181\u20139.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"1800_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.numecd.2015.10.011","volume":"26","author":"X Xia","year":"2016","unstructured":"Xia X, Zhao C, Peng FF, Luo QM, Zhou Q, Lin ZC, et al. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes. Nutr Metab Cardiovasc Dis. 2016;26(1):20\u20136.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"1800_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.ajkd.2013.08.027","volume":"64","author":"X Xia","year":"2014","unstructured":"Xia X, He F, Wu X, Peng F, Huang F, Yu X. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis. 2014;64(2):257\u201364.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1800_CR18","doi-asserted-by":"publisher","first-page":"e82342","DOI":"10.1371\/journal.pone.0082342","volume":"9","author":"J Dong","year":"2014","unstructured":"Dong J, Han QF, Zhu TY, Ren YP, Chen JH, Zhao HP, et al. The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients. PLoS One. 2014;9(1):e82342.","journal-title":"PLoS One"},{"issue":"11","key":"1800_CR19","doi-asserted-by":"publisher","first-page":"E416","DOI":"10.3390\/jcm7110416","volume":"7","author":"KJ Lai","year":"2018","unstructured":"Lai KJ, Kor CT, Hsieh YP. An Inverse Relationship between Hyperuricemia and Mortality in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis. J Clin Med. 2018;7(11):E416.","journal-title":"J Clin Med"},{"issue":"3","key":"1800_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","volume":"70","author":"AB Vargas-Santos","year":"2017","unstructured":"Vargas-Santos AB, Neogi T. Management of Gout and Hyperuricemia in CKD. Am J Kidney Dis. 2017;70(3):422\u201339.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1800_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ki.1978.153","volume":"14","author":"M Robson","year":"1978","unstructured":"Robson M, Oreopoulos DG, Izatt S, Ogilvie R, Rapoport A, de Veber GA. Influence of exchange volume and dialysate flow rate on solute clearance in peritoneal dialysis. Kidney Int. 1978;14(5):486\u201390.","journal-title":"Kidney Int"},{"key":"1800_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089686088700700306","volume":"7","author":"ZJ Twardowski","year":"1987","unstructured":"Twardowski ZJ, Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Int. 1987;7:138\u201348.","journal-title":"Perit Dial Int"},{"issue":"4","key":"1800_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1017\/S0007114514004061","volume":"113","author":"R Huang","year":"2015","unstructured":"Huang R, Liu Y, Wu H, Guo Q, Yi C, Lin J, et al. Lower plasma visceral protein concentrations are independently associated with higher mortality in patients on peritoneal dialysis. Br J Nutr. 2015;113(4):627\u201333.","journal-title":"Br J Nutr"},{"issue":"5","key":"1800_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"1800_CR25","first-page":"303","volume":"5","author":"D Du Bois","year":"1989","unstructured":"Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303\u201311.","journal-title":"Nutrition"},{"issue":"3","key":"1800_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ki.1990.73","volume":"37","author":"A Kagan","year":"1990","unstructured":"Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Kinetics of peritoneal protein loss during CAPD: I. different characteristics for low and high molecular weight proteins. Kidney Int. 1990;37(3):971\u20139.","journal-title":"Kidney Int"},{"issue":"3","key":"1800_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1475-097X.1996.tb00575.x","volume":"16","author":"J Graff","year":"1996","unstructured":"Graff J, Fugleberg S, Brahm J, Fogh-Andersen N. The transport of phosphate between the plasma and dialysate compartments in peritoneal dialysis is influenced by an electric potential difference. Clin Physiol. 1996;16(3):291\u2013300.","journal-title":"Clin Physiol"},{"issue":"1","key":"1800_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ki.1984.15","volume":"25","author":"GA Kaysen","year":"1984","unstructured":"Kaysen GA, Schoenfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1984;25(1):107\u201314.","journal-title":"Kidney Int"},{"issue":"1","key":"1800_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000498841","volume":"44","author":"J Fan","year":"2019","unstructured":"Fan J, Ye H, Zhang X, Cao P, Guo Q, Mao H, et al. Association of Lean Body Mass Index and Peritoneal Protein Clearance in peritoneal Dialysis patients. Kidney Blood Press Res. 2019;44(1):94\u2013102.","journal-title":"Kidney Blood Press Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01800-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01800-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T19:24:15Z","timestamp":1619292255000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01800-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1800"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01800-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18171\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18171\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18171\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18171\/v3","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,25]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has conformed to the ethical principles of the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University. And all patients had signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}